Written by CBD-Intel || 22nd June 2020 || Business briefing |
The use of CBD-based products has reduced the consumption of prescription drugs in Italy, according to a discussion paper from an international economics think-tank ...
Restricted content. Do you want to read more?
The data or analysis report you have tried to access is restricted to our subscribers. We invite you to take a free trial below where you will get access to a limited set of our content.
You can find available reports for purchase in our online store . Reports not listed in the store are available under request. If you are interested in a subscription, get in contact to discuss our subscription plans or to upgrade your current access.
Register
Sign up NOW for 7 days FREE TRIAL and access our briefings section
Register Here
Visit store
Check out our reports available for purchase
View reports
CBD-Intel provides premium market and regulatory analysis, legal tracking, and quantitative data for the cannabidiol (CBD) sectors, with a focus on non-US markets.
We provide our clients with the tools to navigate this fast-moving sector, tailor their business strategy, optimise resources and make informed decisions.
